X
Xiangdong Wang
Researcher at Fudan University
Publications - 375
Citations - 10079
Xiangdong Wang is an academic researcher from Fudan University. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 353 publications receiving 7979 citations. Previous affiliations of Xiangdong Wang include Zhejiang University & Lund University.
Papers
More filters
Journal ArticleDOI
The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine
TL;DR: The goal of this article is to summarize and evaluate the results of experimental findings in LPS-induced ALI/ARDS, and the possible mechanisms and treatments elucidated, and disadvantages of such models in pulmonary research and new directions for future investigations are discussed.
Journal ArticleDOI
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.
Yun-Fan Sun,Liang Wu,Liang Wu,Yu Zhong,Kai-Qian Zhou,Yong Hou,Zifei Wang,Ze-Fan Zhang,J. Xie,Chunqing Wang,Dandan Chen,Yaling Huang,Xiaochan Wei,Ying-Hong Shi,Zhikun Zhao,Yue-Hua Li,Zi-Wei Guo,Qichao Yu,Liqin Xu,Giacomo Volpe,Shuang-Jian Qiu,Jian Zhou,Carl Ward,Hui-Chuan Sun,Ye Yin,Xun Xu,Xiangdong Wang,Miguel A. Esteban,Huanming Yang,Jian Wang,Michael Dean,Yaguang Zhang,Shiping Liu,Xin-Rong Yang,Jia Fan +34 more
TL;DR: A comprehensive picture of the HCC ecosystem provides deeper insights into immune evasion mechanisms associated with tumor relapse, including those that dampen DC antigen presentation and recruit innate-like CD8+ T cells.
Journal ArticleDOI
Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers
TL;DR: The new concept of dynamical network biomarkers (DNBs) has been developed, which is different from traditional static approaches, and the DNB is able to distinguish a predisease state from normal and disease states by even a small number of samples, and therefore has great potential to achieve “real” early diagnosis of complex diseases.
Journal ArticleDOI
The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.
Zhongguang Luo,Guangyang Yu,Hyuk Woo Lee,Lihui Li,Lingyan Wang,Dongqin Yang,Yongfu Pan,Chan Ding,Jing Qian,Lijun Wu,Yiwei Chu,Jing Yi,Xiangdong Wang,Yi Sun,Lak Shin Jeong,Jie Liu,Lijun Jia +16 more
TL;DR: It is reported that MLN4924 also triggers autophagy in response to CRL inactivation and that this effect is important for the ability of MLN 4924 to suppress the outgrowth of liver cancer cells in vitro and in vivo.
Journal ArticleDOI
Autophagy and inflammation.
TL;DR: Recent advances in investigating the roles of autophagy in inflammation as well as inflammatory diseases are highlighted.